BioVaxys Technology Corp. ( BioVaxys) and Sona Nanotech Inc. ( Sona) have entered a Research Agreement to develop new cancer ...

Hyperthermia therapy is a medical treatment that utilizes heat to treat a variety of conditions, particularly cancer. It entails increasing the body’s temperature or focusing on a specific area ...

The BSD-2000 provides deep regional therapeutic hyperthermia to solid tumors (primarily for cervical cancer) by applying ... During a treatment, the cancerous tumor is heated to 40 and 45°C ...

Some of these cancerous mutations in DNA are inherited, while others arise from errors that occur as a cell divides.

Report Ocean has published a new report on the Hyperthermia Cancer Treatment Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report ...

The heat for THT is delivered to tumors using infrared light that is absorbed by Sona's proprietary biocompatible Gold Nanorod technology which elicits a strong immune response. BioVaxys Technology ...

The following is a summary of "Impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in ...

CNW/ -- (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc. (CSE: SONA) (OTC: SNANF) ("Sona") announce ...

Any novel candidate therapeutic developed in this program will be co-owned and co-prosecuted by BioVaxys and Sona, with the parties planning to enter into a commercialization agreement for a vaccine ...